G-quadruplex interacting small molecules and drugs: from bench toward bedside

References

• Swygert SG, Peterson CL. Chromatin dynamics. interplay between remodeling enzymes and histone modifications. Biochim Biophys Acta 2014;1839(8):728-36
   PubMed Web of Science ®Google Scholar
• Müller S, Almouzni G. A network of players in H3 histone variant deposition and maintenance at centromeres. Biochim Biophys Acta 2014;1839(3):241-50
   PubMed Web of Science ®Google Scholar
• Chen T, Dent SY. Chromatin modifiers and remodellers: regulators of cellular differentiation. Nat Rev Genet 2014;15(2):93-106
   PubMed Web of Science ®Google Scholar
• Papamichos-Chronakis M, Peterson CL. Chromatin and the genome integrity network. Nat Rev Genet 2013;14(1):62-75
   PubMed Web of Science ®Google Scholar
• van Steensel B. Chromatin: constructing the big picture. EMBO J 2011;30(10):1885-95
   Google Scholar
• Ghosh A, Bansal M. A glossary of DNA structures from A to Z. Acta Crystallogr D Biol Crystallogr 2003;59(Pt 4):620-6
   PubMedGoogle Scholar
• Zhao J, Bacolla A, Wang G, Vasquez KM. Non-B DNA structure-induced genetic instability and evolution. Cell Mol Life Sci 2010;67(1):43-62
   PubMed Web of Science ®Google Scholar
• Gellert M, Lipsett MN, Davies DR. Helix formation by guanylic acid. Proc Natl Acad Sci USA 1962;48:2013-18
   PubMed Web of Science ®Google Scholar
• Gilbert DE, Feigon J. Multistranded DNA structures. Curr Opin Struct Biol 1999;9(3):305-14
   PubMed Web of Science ®Google Scholar
• Parkinson GN, Lee MP, Neidle S. Crystal structure of parallel quadruplexes from human telomeric DNA. Nature 2002;417(6891):876-80
   PubMed Web of Science ®Google Scholar
• Phan AT, Modi YS, Patel DJ. Two-repeat Tetrahymena telomeric d(TGGGGTTGGGGT) Sequence interconverts between asymmetric dimeric G-quadruplexes in solution. J Mol Biol 2004;338(1):93-102
   PubMed Web of Science ®Google Scholar
• Davis JT. G-quartets 40 years later: from 5’-GMP to molecular biology and supramolecular chemistry. Angew Chem Int Ed Engl 2004;43(6):668-98
   PubMed Web of Science ®Google Scholar
• Huppert JL, Balasubramanian S. Prevalence of quadruplexes in the human genome. Nucleic Acids Res 2005;33(9):2908-16
   PubMed Web of Science ®Google Scholar
• Huppert JL, Balasubramanian S. G-quadruplexes in promoters throughout the human genome. Nucleic Acids Res 2007;35(2):406-13
   PubMed Web of Science ®Google Scholar
• Todd AK, Johnston M, Neidle S. Highly prevalent putative quadruplex sequence motifs in human DNA. Nucleic Acids Res 2005;33(9):2901-7
   PubMed Web of Science ®Google Scholar
• Müller S, Kumari S, Rodriguez R, Balasubramanian S. Small-molecule-mediated G-quadruplex isolation from human cells. Nat Chem 2010;2(12):1095-8
   PubMed Web of Science ®Google Scholar
• Rodriguez R, Miller KM, Forment JV, et al. Small-molecule-induced DNA damage identifies alternative DNA structures in human genes. Nat Chem Biol 2012;8(3):301-10
   PubMed Web of Science ®Google Scholar
• Schaffitzel C, Postberg J, Paeschke K, Lipps HJ. Probing telomeric G-quadruplex DNA structures in cells with in vitro generated single-chain antibody fragments. Methods Mol Biol 2010;608:159-81
   PubMedGoogle Scholar
• Biffi G, Di Antonio M, Tannahill D, Balasubramanian S. Visualization and selective chemical targeting of RNA G-quadruplex structures in the cytoplasm of human cells. Nat Chem 2014;6(1):75-80
   PubMed Web of Science ®Google Scholar
• Lam EY, Beraldi D, Tannahill D, Balasubramanian S. G-quadruplex structures are stable and detectable in human genomic DNA. Nat Commun 2013;4:1796
   PubMed Web of Science ®Google Scholar
• Biffi G, Tannahill D, McCafferty J, Balasubramanian S. Quantitative visualization of DNA G-quadruplex structures in human cells. Nat Chem 2013;5(3):182-6
   PubMed Web of Science ®Google Scholar
• Henderson A, Wu Y, Huang YC, et al. Detection of G-quadruplex DNA in mammalian cells. Nucleic Acids Res 2014;42(2):860-9
   PubMed Web of Science ®Google Scholar
• Balasubramanian S, Hurley LH, Neidle S. Targeting G-quadruplexes in gene promoters: a novel anticancer strategy? Nat Rev Drug Discov 2011;10(4):261-75
   PubMed Web of Science ®Google Scholar
• Rangan A, Fedoroff OY, Hurley LH. Induction of duplex to G-quadruplex transition in the c-myc promoter region by a small molecule. J Biol Chem 2001;276(7):4640-6
   PubMed Web of Science ®Google Scholar
• Seenisamy J, Rezler EM, Powell TJ, et al. The dynamic character of the G-quadruplex element in the c-MYC promoter and modification by TMPyP4. J Am Chem Soc 2004;126(28):8702-9
   PubMed Web of Science ®Google Scholar
• Law MJ, Lower KM, Voon HP, et al. ATR-X syndrome protein targets tandem repeats and influences allele-specific expression in a size-dependent manner. Cell 2010;143(3):367-78
   PubMed Web of Science ®Google Scholar
• Cahoon LA, Seifert HS. An alternative DNA structure is necessary for pilin antigenic variation in Neisseria gonorrhoeae. Science 2009;325(5941):764-7
   PubMed Web of Science ®Google Scholar
• Sarkies P, Reams C, Simpson LJ, Sale JE. Epigenetic instability due to defective replication of structured DNA. Mol Cell 2010;40(5):703-13
   PubMed Web of Science ®Google Scholar
• Lipps HJ, Rhodes D. G-quadruplex structures: in vivo evidence and function. Trends Cell Biol 2009;19(8):414-22
   PubMed Web of Science ®Google Scholar
• Bochman ML, Paeschke K, Zakian VA. DNA secondary structures: stability and function of G-quadruplex structures. Nat Rev Genet 2012;13(11):770-80
   PubMed Web of Science ®Google Scholar
• Maizels N, Gray LT. The G4 genome. PLoS Genet 2013;9(4):e1003468
   PubMed Web of Science ®Google Scholar
• Murat P, Balasubramanian S. Existence and consequences of G-quadruplex structures in DNA. Curr Opin Genet Dev 2013;25C:22-9
   Google Scholar
• Baral A,Kumar P, Pathak R, Chowdhury S. Emerging trends in G-quadruplex biology – role in epigenetic and evolutionary events. Mol Biosyst 2013;9(7):1568-75
   PubMedGoogle Scholar
• Wu Y, Brosh RM Jr. G-quadruplex nucleic acids and human disease. FEBS J 2010;277(17):3470-88
   PubMed Web of Science ®Google Scholar
• Balasubramanian S, Neidle S. G-quadruplex nucleic acids as therapeutic targets. Curr Opin Chem Biol 2009;13(3):345-53
   PubMed Web of Science ®Google Scholar
• Miller KM, Rodriguez R. G-quadruplexes: selective DNA targeting for cancer therapeutics? Expert Rev Clin Pharmacol 2011;4(2):139-42
   PubMedGoogle Scholar
• Neidle S. Human telomeric G-quadruplex: the current status of telomeric G-quadruplexes as therapeutic targets in human cancer. FEBS J 2010;277(5):1118-25
   PubMed Web of Science ®Google Scholar
• Shalaby T, Fiaschetti G, Nagasawa K, et al. G-quadruplexes as potential therapeutic targets for embryonal tumors. Molecules 2013;18(10):12500-37
   PubMed Web of Science ®Google Scholar
• Zakian VA. Telomeres: beginning to understand the end. Science 1995;270(5242):1601-7
   PubMed Web of Science ®Google Scholar
• Hemann MT, Greider CW. G-strand overhangs on telomeres in telomerase-deficient mouse cells. Nucleic Acids Res 1999;27(20):3964-9
   PubMed Web of Science ®Google Scholar
• Wang Y, Patel DJ. Solution structure of a parallel-stranded G-quadruplex DNA. J Mol Biol 1993;234(4):1171-83
   PubMed Web of Science ®Google Scholar
• Zhang Z, Dai J, Veliath E, et al. Structure of a two-G-tetrad intramolecular G-quadruplex formed by a variant human telomeric sequence in K+ solution: insights into the interconversion of human telomeric G-quadruplex structures. Nucleic Acids Res 2010;38(3):1009-21
   PubMed Web of Science ®Google Scholar
• Phan AT, Kuryavyi V, Luu KN, Patel DJ. Structure of two intramolecular G-quadruplexes formed by natural human telomere sequences in K+ solution. Nucleic Acids Res 2007;35(19):6517-25
   PubMed Web of Science ®Google Scholar
• Dai J, Carver M, Punchihewa C, et al. Structure of the Hybrid-2 type intramolecular human telomeric G-quadruplex in K+ solution: insights into structure polymorphism of the human telomeric sequence. Nucleic Acids Res 2007;35(15):4927-40
   PubMed Web of Science ®Google Scholar
• Williamson JR, Raghuraman MK, Cech TR. Monovalent cation-induced structure of telomeric DNA: the G-quartet model. Cell 1989;59(5):871-80
   PubMed Web of Science ®Google Scholar
• de Lange T. Shelterin: the protein complex that shapes and safeguards human telomeres. Genes Dev 2005;19(18):2100-10
   PubMed Web of Science ®Google Scholar
• Kim NW, Piatyszek MA, Prowse KR, et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994;266(5193):2011-15
   PubMed Web of Science ®Google Scholar
• Shay JW, Wright WE. Telomerase therapeutics for cancer: challenges and new directions. Nat Rev Drug Discov 2006;5(7):577-84
   PubMed Web of Science ®Google Scholar
• Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011;144(5):646-74
   PubMed Web of Science ®Google Scholar
• Stewart SA, Weinberg RA. Telomeres: cancer to human aging. Annu Rev Cell Dev Biol 2006;22:531-57
   PubMed Web of Science ®Google Scholar
• Erlitzki R, Fry M. Sequence-specific binding protein of single-stranded and unimolecular quadruplex telomeric DNA from rat hepatocytes. J Biol Chem 1997;272(25):15881-90
   PubMed Web of Science ®Google Scholar
• Zahler AM, Williamson JR, Cech TR, Prescott DM. Inhibition of telomerase by G-quartet DNA structures. Nature 1991;350(6320):718-20
   PubMed Web of Science ®Google Scholar
• Ray S, Bandaria JN, Qureshi MH, et al. G-quadruplex formation in telomeres enhances POT1/TPP1 protection against RPA binding. Proc Natl Acad Sci USA 2014;111(8):2990-5
   PubMed Web of Science ®Google Scholar
• Sun D, Thompson B, Cathers BE, et al. Inhibition of human telomerase by a G-quadruplex-interactive compound. J Med Chem 1997;40(14):2113-16
   PubMed Web of Science ®Google Scholar
• Shin-ya K, Wierzba K, Matsuo K, et al. Telomestatin, a novel telomerase inhibitor from Streptomyces anulatus. J Am Chem Soc 2001;123(6):1262-3
   PubMed Web of Science ®Google Scholar
• Temime-Smaali N, Guittat L, Sidibe A, et al. The G-quadruplex ligand telomestatin impairs binding of topoisomerase IIIalpha to G-quadruplex-forming oligonucleotides and uncaps telomeres in ALT cells. PLoS One 2009;4(9):e6919
   Web of Science ®Google Scholar
• Gomez D, O’Donohue MF, Wenner T, et al. The G-quadruplex ligand telomestatin inhibits POT1 binding to telomeric sequences in vitro and induces GFP-POT1 dissociation from telomeres in human cells. Cancer Res 2006;66(14):6908-12
   PubMed Web of Science ®Google Scholar
• Riou JF, Guittat L, Mailliet P, et al. Cell senescence and telomere shortening induced by a new series of specific G-quadruplex DNA ligands. Proc Natl Acad Sci USA 2002;99(5):2672-7
   PubMed Web of Science ®Google Scholar
• Gomez D, Aouali N, Londono-Vallejo A, et al. Resistance to the short term antiproliferative activity of the G-quadruplex ligand 12459 is associated with telomerase overexpression and telomere capping alteration. J Biol Chem 2003;278(50):50554-62
   PubMed Web of Science ®Google Scholar
• Gunaratnam M, Greciano O, Martins C, et al. Mechanism of acridine-based telomerase inhibition and telomere shortening. Biochem Pharmacol 2007;74(5):679-89
   PubMed Web of Science ®Google Scholar
• Leonetti C, Amodei S, D’Angelo C, et al. Biological activity of the G-quadruplex ligand RHPS4 (3,11-difluoro-6,8,13-trimethyl-8H-quino[4,3,2-kl]acridinium methosulfate) is associated with telomere capping alteration. Mol Pharmacol 2004;66(5):1138-46
   PubMed Web of Science ®Google Scholar
• Phatak P, Cookson JC, Dai F, et al. Telomere uncapping by the G-quadruplex ligand RHPS4 inhibits clonogenic tumour cell growth in vitro and in vivo consistent with a cancer stem cell targeting mechanism. Br J Cancer 2007;96(8):1223-33
   PubMed Web of Science ®Google Scholar
• Salvati E, Leonetti C, Rizzo A, et al. Telomere damage induced by the G-quadruplex ligand RHPS4 has an antitumor effect. J Clin Invest 2007;117(11):3236-47
   PubMed Web of Science ®Google Scholar
• Pennarun G, Granotier C, Gauthier LR, et al. Apoptosis related to telomere instability and cell cycle alterations in human glioma cells treated by new highly selective G-quadruplex ligands. Oncogene 2005;24(18):2917-28
   PubMed Web of Science ®Google Scholar
• Granotier C, Pennarun G, Riou L, et al. Preferential binding of a G-quadruplex ligand to human chromosome ends. Nucleic Acids Res 2005;33(13):4182-90
   PubMed Web of Science ®Google Scholar
• Pennarun G, Granotier C, Hoffschir F, et al. Role of ATM in the telomere response to the G-quadruplex ligand 360A. Nucleic Acids Res 2008;36(5):1741-54
   PubMed Web of Science ®Google Scholar
• Lee YR, Yu DS, Liang YC, et al. New approaches of PARP-1 inhibitors in human lung cancer cells and cancer stem-like cells by some selected anthraquinone-derived small molecules. PLoS One 2013;8(2):e56284
   PubMed Web of Science ®Google Scholar
• Chung YL, Pan CH, Liou WH, et al. NSC746364, a G-quadruplex-stabilizing agent, suppresses cell growth of A549 human lung cancer cells through activation of the ATR/Chk1-dependent pathway. J Pharmacol Sci 2014;124(1):7-17
   PubMed Web of Science ®Google Scholar
• Rodriguez R, Muller S, Yeoman JA, et al. A novel small molecule that alters shelterin integrity and triggers a DNA-damage response at telomeres. J Am Chem Soc 2008;130(47):15758-9
   PubMed Web of Science ®Google Scholar
• Jantos K, Rodriguez R, Ladame S, et al. Oxazole-based peptide macrocycles: a new class of G-quadruplex binding ligands. J Am Chem Soc 2006;128(42):13662-3
   PubMed Web of Science ®Google Scholar
• Müller S, Pantos GD, Rodriguez R, Balasubramanian S. Controlled-folding of a small molecule modulates DNA G-quadruplex recognition. Chem Commun (Camb) 2009(1):80-2
   PubMed Web of Science ®Google Scholar
• Perry PJ, Read MA, Davies RT, et al. 2,7-Disubstituted amidofluorenone derivatives as inhibitors of human telomerase. J Med Chem 1999;42(14):2679-84
   PubMed Web of Science ®Google Scholar
• Mergny JL, Lacroix L, Teulade-Fichou MP, et al. Telomerase inhibitors based on quadruplex ligands selected by a fluorescence assay. Proc Natl Acad Sci USA 2001;98(6):3062-7
   PubMed Web of Science ®Google Scholar
• De Cian A, Delemos E, Mergny JL, et al. Highly efficient G-quadruplex recognition by bisquinolinium compounds. J Am Chem Soc 2007;129(7):1856-7
   PubMed Web of Science ®Google Scholar
• Cosconati S, Rizzo A, Trotta R, et al. Shooting for selective drug-like G-quadruplex binders: evidence for telomeric DNA damage and tumor cell death. J Med Chem 2012;55(22):9785-92
   PubMed Web of Science ®Google Scholar
• Monchaud D, Teulade-Fichou MP. A hitchhiker’s guide to G-quadruplex ligands. Org Biomol Chem 2008;6(4):627-36
   PubMed Web of Science ®Google Scholar
• Müller S, Sanders DA, Di Antonio M, et al. Pyridostatin analogues promote telomere dysfunction and long-term growth inhibition in human cancer cells. Org Biomol Chem 2012;10(32):6537-46
   PubMed Web of Science ®Google Scholar
• d’Adda di Fagagna F, Reaper PM, Clay-Farrace L, et al. A DNA damage checkpoint response in telomere-initiated senescence. Nature 2003;426(6963):194-8
   PubMed Web of Science ®Google Scholar
• Yang P, De Cian A, Teulade-Fichou MP, et al. Engineering bisquinolinium/thiazole orange conjugates for fluorescent sensing of G-quadruplex DNA. Angew Chem Int Ed Engl 2009;48(12):2188-91
   PubMed Web of Science ®Google Scholar
• Monchaud D, Allain C, Teulade-Fichou MP. Thiazole orange: a useful probe for fluorescence sensing of G-quadruplex-ligand interactions. Nucleosides Nucleotides Nucleic Acids 2007;26(10-12):1585-8
   PubMed Web of Science ®Google Scholar
• Zhang DH, Zhou B, Huang Y, et al. The human Pif1 helicase, a potential Escherichia coli RecD homologue, inhibits telomerase activity. Nucleic Acids Res 2006;34(5):1393-404
   PubMed Web of Science ®Google Scholar
• Bochman ML, Sabouri N, Zakian VA. Unwinding the functions of the Pif1 family helicases. DNA Repair (Amst) 2010;9(3):237-49
   PubMed Web of Science ®Google Scholar
• Paeschke K, Bochman ML, Garcia PD, et al. Pif1 family helicases suppress genome instability at G-quadruplex motifs. Nature 2013;497(7450):458-62
   PubMed Web of Science ®Google Scholar
• Koole W, van Schendel R, Karambelas AE, et al. A Polymerase Theta-dependent repair pathway suppresses extensive genomic instability at endogenous G4 DNA sites. Nat Commun 2014;5:3216
   PubMed Web of Science ®Google Scholar
• Siddiqui-Jain A, Grand CL, Bearss DJ, Hurley LH. Direct evidence for a G-quadruplex in a promoter region and its targeting with a small molecule to repress c-MYC transcription. Proc Natl Acad Sci USA 2002;99(18):11593-8
   PubMed Web of Science ®Google Scholar
• Huppert JL, Bugaut A, Kumari S, Balasubramanian S. G-quadruplexes: the beginning and end of UTRs. Nucleic Acids Res 2008;36(19):6260-8
   PubMed Web of Science ®Google Scholar
• Kumari S, Bugaut A, Huppert JL, Balasubramanian S. An RNA G-quadruplex in the 5’ UTR of the NRAS proto-oncogene modulates translation. Nat Chem Biol 2007;3(4):218-21
   PubMed Web of Science ®Google Scholar
• Gomez D, Guedin A, Mergny JL, et al. A G-quadruplex structure within the 5’-UTR of TRF2 mRNA represses translation in human cells. Nucleic Acids Res 2010;38(20):7187-98
   PubMed Web of Science ®Google Scholar
• Bugaut A, Rodriguez R, Kumari S, et al. Small molecule-mediated inhibition of translation by targeting a native RNA G-quadruplex. Org Biomol Chem 2010;8(12):2771-6
   PubMed Web of Science ®Google Scholar
• Arora A, Dutkiewicz M, Scaria V, et al. Inhibition of translation in living eukaryotic cells by an RNA G-quadruplex motif. RNA 2008;14(7):1290-6
   PubMed Web of Science ®Google Scholar
• Murat P, Zhong J, Lekieffre L, et al. G-quadruplexes regulate Epstein-Barr virus-encoded nuclear antigen 1 mRNA translation. Nat Chem Biol 2014;10(5):358-64
   PubMed Web of Science ®Google Scholar
• Rankin S, Reszka AP, Huppert J, et al. Putative DNA quadruplex formation within the human c-kit oncogene. J Am Chem Soc 2005;127(30):10584-9
   PubMed Web of Science ®Google Scholar
• Fernando H, Reszka AP, Huppert J, et al. A conserved quadruplex motif located in a transcription activation site of the human c-kit oncogene. Biochemistry 2006;45(25):7854-60
   PubMed Web of Science ®Google Scholar
• Heinrich MC, Corless CL, Demetri GD, et al. Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor. J Clin Oncol 2003;21(23):4342-9
   PubMed Web of Science ®Google Scholar
• Cogoi S, Xodo LE. G-quadruplex formation within the promoter of the KRAS proto-oncogene and its effect on transcription. Nucleic Acids Res 2006;34(9):2536-49
   PubMed Web of Science ®Google Scholar
• Neidle S. The structures of quadruplex nucleic acids and their drug complexes. Curr Opin Struct Biol 2009;19(3):239-50
   PubMed Web of Science ®Google Scholar
• Ambrus A, Chen D, Dai J, et al. Solution structure of the biologically relevant G-quadruplex element in the human c-MYC promoter. Implications for G-quadruplex stabilization. Biochemistry 2005;44(6):2048-58
   PubMed Web of Science ®Google Scholar
• Wei D, Todd AK, Zloh M, et al. Crystal structure of a promoter sequence in the B-raf gene reveals an intertwined dimer quadruplex. J Am Chem Soc 2013;135(51):19319-29
   PubMed Web of Science ®Google Scholar
• Wei D, Parkinson GN, Reszka AP, Neidle S. Crystal structure of a c-kit promoter quadruplex reveals the structural role of metal ions and water molecules in maintaining loop conformation. Nucleic Acids Res 2012;40(10):4691-700
   PubMed Web of Science ®Google Scholar
• Tong X, Lan W, Zhang X, et al. Solution structure of all parallel G-quadruplex formed by the oncogene RET promoter sequence. Nucleic Acids Res 2011;39(15):6753-63
   PubMed Web of Science ®Google Scholar
• Shklover J, Weisman-Shomer P, Yafe A, Fry M. Quadruplex structures of muscle gene promoter sequences enhance in vivo MyoD-dependent gene expression. Nucleic Acids Res 2010;38(7):2369-77
   PubMed Web of Science ®Google Scholar
• Phan AT, Modi YS, Patel DJ. Propeller-type parallel-stranded G-quadruplexes in the human c-myc promoter. J Am Chem Soc 2004;126(28):8710-16
   PubMed Web of Science ®Google Scholar
• Dexheimer TS, Carey SS, Zuohe S, et al. NM23-H2 may play an indirect role in transcriptional activation of c-myc gene expression but does not cleave the nuclease hypersensitive element III(1). Mol Cancer Ther 2009;8(5):1363-77
   PubMed Web of Science ®Google Scholar
• Gonzalez V, Guo K, Hurley L, Sun D. Identification and characterization of nucleolin as a c-myc G-quadruplex-binding protein. J Biol Chem 2009;284(35):23622-35
   PubMed Web of Science ®Google Scholar
• Thakur RK, Kumar P, Halder K, et al. Metastases suppressor NM23-H2 interaction with G-quadruplex DNA within c-MYC promoter nuclease hypersensitive element induces c-MYC expression. Nucleic Acids Res 2009;37(1):172-83
   PubMed Web of Science ®Google Scholar
• Boddupally PV, Hahn S, Beman C, et al. Anticancer activity and cellular repression of c-MYC by the G-quadruplex-stabilizing 11-piperazinylquindoline is not dependent on direct targeting of the G-quadruplex in the c-MYC promoter. J Med Chem 2012;55(13):6076-86
   PubMed Web of Science ®Google Scholar
• Ou TM, Lu YJ, Zhang C, et al. Stabilization of G-quadruplex DNA and down-regulation of oncogene c-myc by quindoline derivatives. J Med Chem 2007;50(7):1465-74
   PubMed Web of Science ®Google Scholar
• Ou TM, Lin J, Lu YJ, et al. Inhibition of cell proliferation by quindoline derivative (SYUIQ-05) through its preferential interaction with c-myc promoter G-quadruplex. J Med Chem 2011;54(16):5671-9
   PubMed Web of Science ®Google Scholar
• Kang HJ, Park HJ. Novel molecular mechanism for actinomycin D activity as an oncogenic promoter G-quadruplex binder. Biochemistry 2009;48(31):7392-8
   PubMed Web of Science ®Google Scholar
• Chung WJ, Heddi B, Hamon F, et al. Solution structure of a G-quadruplex bound to the bisquinolinium compound Phen-DC(3). Angew Chem Int Ed Engl 2014;53(4):999-1002
   PubMed Web of Science ®Google Scholar
• Wang P, Leung CH, Ma DL, et al. Structure-based design of platinum(II) complexes as c-myc oncogene down-regulators and luminescent probes for G-quadruplex DNA. Chemistry (Easton) 2010;16(23):6900-11
   Web of Science ®Google Scholar
• Shalaby T, von Bueren AO, Hurlimann ML, et al. Disabling c-Myc in childhood medulloblastoma and atypical teratoid/rhabdoid tumor cells by the potent G-quadruplex interactive agent S2T1-6OTD. Mol Cancer Ther 2010;9(1):167-79
   PubMed Web of Science ®Google Scholar
• Xu CX, Zheng YX, Zheng XH, et al. V-shaped dinuclear Pt(II) complexes: selective interaction with human telomeric G-quadruplex and significant inhibition towards telomerase. Sci Rep 2013;3:2060
   PubMed Web of Science ®Google Scholar
• Sedoris KC, Thomas SD, Clarkson CR, et al. Genomic c-Myc quadruplex DNA selectively kills leukemia. Mol Cancer Ther 2012;11(1):66-76
   PubMed Web of Science ®Google Scholar
• Islam MA, Thomas SD, Murty VV, et al. c-Myc Quadruplex-forming Sequence Pu-27 Induces Extensive Damage in Both Telomeric and Nontelomeric Regions of DNA. J Biol Chem 2014;289(12):8521-31
   PubMed Web of Science ®Google Scholar
• Gunaratnam M, Swank S, Haider SM, et al. Targeting human gastrointestinal stromal tumor cells with a quadruplex-binding small molecule. J Med Chem 2009;52(12):3774-83
   PubMed Web of Science ®Google Scholar
• Bejugam M, Sewitz S, Shirude PS, et al. Trisubstituted isoalloxazines as a new class of G-quadruplex binding ligands: small molecule regulation of c-kit oncogene expression. J Am Chem Soc 2007;129(43):12926-7
   PubMed Web of Science ®Google Scholar
• Bejugam M, Gunaratnam M, Müller S, et al. Targeting the c-Kit promoter G-quadruplexes with 6-substituted indenoisoquinolines. ACS Med Chem Lett 2010;1:306-10
   PubMed Web of Science ®Google Scholar
• McLuckie KI, Waller ZA, Sanders DA, et al. G-quadruplex-binding benzo[a]phenoxazines down-regulate c-KIT expression in human gastric carcinoma cells. J Am Chem Soc 2011;133(8):2658-63
   PubMed Web of Science ®Google Scholar
• Shen FH, Jin J, Li J, et al. The G-quadruplex ligand, SYUIQ-FM05, targets proto-oncogene c-kit transcription and induces apoptosis in K562 cells. Pharm Biol 2013;51(4):447-54
   PubMed Web of Science ®Google Scholar
• Raiber EA, Kranaster R, Lam E, et al. A non-canonical DNA structure is a binding motif for the transcription factor SP1 in vitro. Nucleic Acids Res 2012;40(4):1499-508
   PubMed Web of Science ®Google Scholar
• Liu JN, Deng R, Guo JF, et al. Inhibition of myc promoter and telomerase activity and induction of delayed apoptosis by SYUIQ-5, a novel G-quadruplex interactive agent in leukemia cells. Leukemia 2007;21(6):1300-2
   PubMed Web of Science ®Google Scholar
• Sun H, Karow JK, Hickson ID, Maizels N. The Bloom’s syndrome helicase unwinds G4 DNA. J Biol Chem 1998;273(42):27587-92
   PubMed Web of Science ®Google Scholar
• Eddy S, Ketkar A, Zafar MK, et al. Human Rev1 polymerase disrupts G-quadruplex DNA. Nucleic Acids Res 2014;42(5):3272-85
   PubMed Web of Science ®Google Scholar
• Schwab RA, Nieminuszczy J, Shin-ya K, Niedzwiedz W. FANCJ couples replication past natural fork barriers with maintenance of chromatin structure. J Cell Biol 2013;201(1):33-48
   PubMed Web of Science ®Google Scholar
• Mohaghegh P, Karow JK, Brosh RM Jr, et al. The Bloom’s and Werner’s syndrome proteins are DNA structure-specific helicases. Nucleic Acids Res 2001;29(13):2843-9
   PubMed Web of Science ®Google Scholar
• Fry M, Loeb LA. Human Werner syndrome DNA helicase unwinds tetrahelical structures of the fragile X syndrome repeat sequence d(CGG)n. J Biol Chem 1999;274(18):12797-802
   PubMed Web of Science ®Google Scholar
• Brosh RM Jr, Bohr VA. Human premature aging, DNA repair and RecQ helicases. Nucleic Acids Res 2007;35(22):7527-44
   PubMed Web of Science ®Google Scholar
• Damerla RR, Knickelbein KE, Strutt S, et al. Werner syndrome protein suppresses the formation of large deletions during the replication of human telomeric sequences. Cell Cycle 2012;11(16):3036-44
   PubMed Web of Science ®Google Scholar
• Li JL, Harrison RJ, Reszka AP, et al. Inhibition of the Bloom’s and Werner’s syndrome helicases by G-quadruplex interacting ligands. Biochemistry 2001;40(50):15194-202
   PubMed Web of Science ®Google Scholar
• Wu Y, Shin-ya K, Brosh RM Jr. FANCJ helicase defective in Fanconi anemia and breast cancer unwinds G-quadruplex DNA to defend genomic stability. Mol Cell Biol 2008;28(12):4116-28
   PubMed Web of Science ®Google Scholar
• Wu Y, Suhasini AN, Brosh RM Jr. Welcome the family of FANCJ-like helicases to the block of genome stability maintenance proteins. Cell Mol Life Sci 2009;66(7):1209-22
   PubMed Web of Science ®Google Scholar
• London TB, Barber LJ, Mosedale G, et al. FANCJ is a structure-specific DNA helicase associated with the maintenance of genomic G/C tracts. J Biol Chem 2008;283(52):36132-9
   PubMed Web of Science ®Google Scholar
• Bharti SK, Sommers JA, George F, et al. Specialization among iron-sulfur cluster helicases to resolve G-quadruplex DNA structures that threaten genomic stability. J Biol Chem 2013;288(39):28217-29
   PubMed Web of Science ®Google Scholar
• Kruisselbrink E, Guryev V, Brouwer K, et al. Mutagenic capacity of endogenous G4 DNA underlies genome instability in FANCJ-defective C. elegans. Curr Biol 2008;18(12):900-5
   PubMed Web of Science ®Google Scholar
• Chai W, Zheng L, Shen B. DNA2, a new player in telomere maintenance and tumor suppression. Cell Cycle 2013;12(13):1985-6
   PubMed Web of Science ®Google Scholar
• Lin W, Sampathi S, Dai H, et al. Mammalian DNA2 helicase/nuclease cleaves G-quadruplex DNA and is required for telomere integrity. EMBO J 2013;32(10):1425-39
   PubMed Web of Science ®Google Scholar
• Vaughn JP, Creacy SD, Routh ED, et al. The DEXH protein product of the DHX36 gene is the major source of tetramolecular quadruplex G4-DNA resolving activity in HeLa cell lysates. J Biol Chem 2005;280(46):38117-20
   PubMed Web of Science ®Google Scholar
• Giri B, Smaldino PJ, Thys RG, et al. G4 resolvase 1 tightly binds and unwinds unimolecular G4-DNA. Nucleic Acids Res 2011;39(16):7161-78
   PubMed Web of Science ®Google Scholar
• Creacy SD, Routh ED, Iwamoto F, et al. G4 resolvase 1 binds both DNA and RNA tetramolecular quadruplex with high affinity and is the major source of tetramolecular quadruplex G4-DNA and G4-RNA resolving activity in HeLa cell lysates. J Biol Chem 2008;283(50):34626-34
   PubMed Web of Science ®Google Scholar
• Tran H, Schilling M, Wirbelauer C, et al. Facilitation of mRNA deadenylation and decay by the exosome-bound, DExH protein RHAU. Mol Cell 2004;13(1):101-11
   PubMed Web of Science ®Google Scholar
• Meier M, Patel TR, Booy EP, et al. Binding of G-quadruplexes to the N-terminal recognition domain of the RNA helicase associated with AU-rich element (RHAU). J Biol Chem 2013;288(49):35014-27
   PubMed Web of Science ®Google Scholar
• Lattmann S, Stadler MB, Vaughn JP, et al. The DEAH-box RNA helicase RHAU binds an intramolecular RNA G-quadruplex in TERC and associates with telomerase holoenzyme. Nucleic Acids Res 2011;39(21):9390-404
   PubMed Web of Science ®Google Scholar
• Vannier JB, Pavicic-Kaltenbrunner V, Petalcorin MI, et al. RTEL1 dismantles T loops and counteracts telomeric G4-DNA to maintain telomere integrity. Cell 2012;149(4):795-806
   PubMed Web of Science ®Google Scholar
• Vannier JB, Sandhu S, Petalcorin MI, et al. RTEL1 is a replisome-associated helicase that promotes telomere and genome-wide replication. Science 2013;342(6155):239-42
   PubMed Web of Science ®Google Scholar
• Gray LT, Vallur AC, Eddy J, Maizels N. G quadruplexes are genome-wide targets of transcriptional helicases XPB and XPD. Nat Chem Biol 2014;10(4):313-18
   PubMed Web of Science ®Google Scholar
• Budd ME, Reis CC, Smith S, et al. Evidence suggesting that Pif1 helicase functions in DNA replication with the Dna2 helicase/nuclease and DNA polymerase delta. Mol Cell Biol 2006;26(7):2490-500
   PubMed Web of Science ®Google Scholar
• Paeschke K, Capra JA, Zakian VA. DNA replication through G-quadruplex motifs is promoted by the Saccharomyces cerevisiae Pif1 DNA helicase. Cell 2011;145(5):678-91
   PubMed Web of Science ®Google Scholar
• Ribeyre C, Lopes J, Boule JB, et al. The yeast Pif1 helicase prevents genomic instability caused by G-quadruplex-forming CEB1 sequences in vivo. PLoS Genet 2009;5(5):e1000475
   PubMed Web of Science ®Google Scholar
• Sarkies P, Murat P, Phillips LG, et al. FANCJ coordinates two pathways that maintain epigenetic stability at G-quadruplex DNA. Nucleic Acids Res 2012;40(4):1485-98
   PubMed Web of Science ®Google Scholar
• Waddington CH, Kacser H. The strategy of the genes, a discussion of some aspects of theoretical biology. Allen & Unwin; Crows Nest, Australia: 1957
   Google Scholar
• Lennartsson A, Ekwall K. Histone modification patterns and epigenetic codes. Biochim Biophys Acta 2009;1790(9):863-8
   PubMed Web of Science ®Google Scholar
• Kim MY, Vankayalapati H, Shin-Ya K, et al. Telomestatin, a potent telomerase inhibitor that interacts quite specifically with the human telomeric intramolecular g-quadruplex. J Am Chem Soc 2002;124(10):2098-9
   PubMed Web of Science ®Google Scholar
• Shammas MA, Shmookler Reis RJ, Li C, et al. Telomerase inhibition and cell growth arrest after telomestatin treatment in multiple myeloma. Clin Cancer Res 2004;10(2):770-6
   PubMed Web of Science ®Google Scholar
• Nakajima A, Tauchi T, Sashida G, et al. Telomerase inhibition enhances apoptosis in human acute leukemia cells: possibility of antitelomerase therapy. Leukemia 2003;17(3):560-7
   PubMed Web of Science ®Google Scholar
• Sumi M, Tauchi T, Sashida G, et al. A G-quadruplex-interactive agent, telomestatin (SOT-095), induces telomere shortening with apoptosis and enhances chemosensitivity in acute myeloid leukemia. Int J Oncol 2004;24(6):1481-7
   PubMed Web of Science ®Google Scholar
• Tauchi T, Shin-ya K, Sashida G, et al. Telomerase inhibition with a novel G-quadruplex-interactive agent, telomestatin: in vitro and in vivo studies in acute leukemia. Oncogene 2006;25(42):5719-25
   PubMed Web of Science ®Google Scholar
• Miyazaki T, Pan Y, Joshi K, et al. Telomestatin impairs glioma stem cell survival and growth through the disruption of telomeric G-quadruplex and inhibition of the proto-oncogene, c-Myb. Clin Cancer Res 2012;18(5):1268-80
   PubMed Web of Science ®Google Scholar
• Doi T, Yoshida M, Shin-ya K, Takahashi T. Total synthesis of (R)-telomestatin. Org Lett 2006;8(18):4165-7
   PubMed Web of Science ®Google Scholar
• Linder J, Garner TP, Williams HE, et al. Telomestatin: formal total synthesis and cation-mediated interaction of its seco-derivatives with G-quadruplexes. J Am Chem Soc 2011;133(4):1044-51
   PubMed Web of Science ®Google Scholar
• Iida K, Tera M, Hirokawa T, et al. G-quadruplex recognition by macrocyclic hexaoxazole (6OTD) dimer: greater selectivity than monomer. Chem Commun (Camb) 2009(42):6481-3
   PubMed Web of Science ®Google Scholar
• Iida K, Tera M, Shin-Ya K, Nagasawa K. G-quadruplex recognition by macrocyclic hexaoxazole (6OTD) dimer. Nucleic Acids Symp Ser (Oxf) 2009(53):233-4
   PubMedGoogle Scholar
• Petenzi M, Verga D, Largy E, et al. Cationic pentaheteroaryls as selective G-quadruplex ligands by solvent-free microwave-assisted synthesis. Chemistry (Easton) 2012;18(45):14487-96
   Web of Science ®Google Scholar
• Wu X, Maizels N. Substrate-specific inhibition of RecQ helicase. Nucleic Acids Res 2001;29(8):1765-71
   PubMed Web of Science ®Google Scholar
• Grand CL, Han H, Munoz RM, et al. The cationic porphyrin TMPyP4 down-regulates c-MYC and human telomerase reverse transcriptase expression and inhibits tumor growth in vivo. Mol Cancer Ther 2002;1(8):565-73
   PubMed Web of Science ®Google Scholar
• Guliaev AB, Leontis NB. Cationic 5,10,15,20-tetrakis(N-methylpyridinium-4-yl)porphyrin fully intercalates at 5’-CG-3’ steps of duplex DNA in solution. Biochemistry 1999;38(47):15425-37
   PubMed Web of Science ®Google Scholar
• Lee YA, Kim JO, Cho TS, et al. Binding of meso-tetrakis(N-methylpyridium-4-yl)porphyrin to triplex oligonucleotides: evidence for the porphyrin stacking in the major groove. J Am Chem Soc 2003;125(27):8106-7
   PubMed Web of Science ®Google Scholar
• Dixon IM, Lopez F, Tejera AM, et al. A G-quadruplex ligand with 10000-fold selectivity over duplex DNA. J Am Chem Soc 2007;129(6):1502-3
   PubMed Web of Science ®Google Scholar
• Mikami-Terao Y, Akiyama M, Yuza Y, et al. Antitumor activity of G-quadruplex-interactive agent TMPyP4 in K562 leukemic cells. Cancer Lett 2008;261(2):226-34
   PubMed Web of Science ®Google Scholar
• Mikami-Terao Y, Akiyama M, Yuza Y, et al. Antitumor activity of TMPyP4 interacting G-quadruplex in retinoblastoma cell lines. Exp Eye Res 2009;89(2):200-8
   PubMed Web of Science ®Google Scholar
• Fujimori J, Matsuo T, Shimose S, et al. Antitumor effects of telomerase inhibitor TMPyP4 in osteosarcoma cell lines. J Orthop Res 2011;29(11):1707-11
   PubMed Web of Science ®Google Scholar
• Shammas MA, Shmookler Reis RJ, Akiyama M, et al. Telomerase inhibition and cell growth arrest by G-quadruplex interactive agent in multiple myeloma. Mol Cancer Ther 2003;2(9):825-33
   PubMed Web of Science ®Google Scholar
• Rha SY, Izbicka E, Lawrence R, et al. Effect of telomere and telomerase interactive agents on human tumor and normal cell lines. Clin Cancer Res 2000;6(3):987-93
   PubMed Web of Science ®Google Scholar
• Liu AH, Sun X, Wei XQ, Zhang YZ. Efficacy of multiple low-dose photodynamic TMPYP4 therapy on cervical cancer tumour growth in nude mice. Asian Pac J Cancer Prev 2013;14(9):5371-4
   PubMedGoogle Scholar
• Rapozzi V, Zorzet S, Zacchigna M, et al. Anticancer activity of cationic porphyrins in melanoma tumour-bearing mice and mechanistic in vitro studies. Mol Cancer 2014;13(1):75
   PubMedGoogle Scholar
• Zamiri B, Reddy K, Macgregor RB Jr, Pearson CE. TMPyP4 porphyrin distorts RNA G-quadruplex structures of the disease-associated r(GGGGCC)n repeat of the C9orf72 gene and blocks interaction of RNA-binding proteins. J Biol Chem 2014;289(8):4653-9
   PubMed Web of Science ®Google Scholar
• Read M, Harrison RJ, Romagnoli B, et al. Structure-based design of selective and potent G quadruplex-mediated telomerase inhibitors. Proc Natl Acad Sci USA 2001;98(9):4844-9
   PubMed Web of Science ®Google Scholar
• Harrison RJ, Cuesta J, Chessari G, et al. Trisubstituted acridine derivatives as potent and selective telomerase inhibitors. J Med Chem 2003;46(21):4463-76
   PubMed Web of Science ®Google Scholar
• Incles CM, Schultes CM, Kempski H, et al. A G-quadruplex telomere targeting agent produces p16-associated senescence and chromosomal fusions in human prostate cancer cells. Mol Cancer Ther 2004;3(10):1201-6
   PubMed Web of Science ®Google Scholar
• Gowan SM, Harrison JR, Patterson L, et al. A G-quadruplex-interactive potent small-molecule inhibitor of telomerase exhibiting in vitro and in vivo antitumor activity. Mol Pharmacol 2002;61(5):1154-62
   PubMed Web of Science ®Google Scholar
• Kelland LR. Overcoming the immortality of tumour cells by telomere and telomerase based cancer therapeutics – current status and future prospects. Eur J Cancer 2005;41(7):971-9
   PubMed Web of Science ®Google Scholar
• Burger AM, Dai F, Schultes CM, et al. The G-quadruplex-interactive molecule BRACO-19 inhibits tumor growth, consistent with telomere targeting and interference with telomerase function. Cancer Res 2005;65(4):1489-96
   PubMed Web of Science ®Google Scholar
• Taetz S, Murdter TE, Zapp J, et al. Decomposition of the telomere-targeting agent BRACO19 in physiological media results in products with decreased inhibitory potential. Int J Pharm 2008;357(1-2):6-14
   PubMedGoogle Scholar
• Taetz S, Baldes C, Murdter TE, et al. Biopharmaceutical characterization of the telomerase inhibitor BRACO19. Pharm Res 2006;23(5):1031-7
   PubMed Web of Science ®Google Scholar
• Debray J, Zeghida W, Jourdan M, et al. Synthesis and evaluation of fused bispyrimidinoacridines as novel pentacyclic analogues of quadruplex-binder BRACO-19. Org Biomol Chem 2009;7(24):5219-28
   PubMed Web of Science ®Google Scholar
• Cookson JC, Dai F, Smith V, et al. Pharmacodynamics of the G-quadruplex-stabilizing telomerase inhibitor 3,11-difluoro-6,8,13-trimethyl-8H-quino[4,3,2-kl]acridinium methosulfate (RHPS4) in vitro: activity in human tumor cells correlates with telomere length and can be enhanced, or antagonized, with cytotoxic agents. Mol Pharmacol 2005;68(6):1551-8
   PubMed Web of Science ®Google Scholar
• Lagah S, Tan IL, Radhakrishnan P, et al. RHPS4 G-quadruplex ligand induces anti-proliferative effects in brain tumor cells. PLoS One 2014;9(1):e86187
   PubMed Web of Science ®Google Scholar
• Salvati E, Scarsella M, Porru M, et al. PARP1 is activated at telomeres upon G4 stabilization: possible target for telomere-based therapy. Oncogene 2010;29(47):6280-93
   PubMed Web of Science ®Google Scholar
• Duan W, Rangan A, Vankayalapati H, et al. Design and synthesis of fluoroquinophenoxazines that interact with human telomeric G-quadruplexes and their biological effects. Mol Cancer Ther 2001;1(2):103-20
   PubMed Web of Science ®Google Scholar
• Drygin D, Siddiqui-Jain A, O’Brien S, et al. Anticancer activity of CX-3543: a direct inhibitor of rRNA biogenesis. Cancer Res 2009;69(19):7653-61
   PubMed Web of Science ®Google Scholar
• Brooks TA, Hurley LH. Targeting MYC expression through G-quadruplexes. Genes Cancer 2010;1(6):641-9
   PubMedGoogle Scholar
• Gomez D, Lemarteleur T, Lacroix L, et al. Telomerase downregulation induced by the G-quadruplex ligand 12459 in A549 cells is mediated by hTERT RNA alternative splicing. Nucleic Acids Res 2004;32(1):371-9
   PubMed Web of Science ®Google Scholar
• Douarre C, Mergui X, Sidibe A, et al. DNA damage signaling induced by the G-quadruplex ligand 12459 is modulated by PPM1D/WIP1 phosphatase. Nucleic Acids Res 2013;41(6):3588-99
   PubMed Web of Science ®Google Scholar
• Lemarteleur T, Gomez D, Paterski R, et al. Stabilization of the c-myc gene promoter quadruplex by specific ligands’ inhibitors of telomerase. Biochem Biophys Res Commun 2004;323(3):802-8
   PubMed Web of Science ®Google Scholar
• Halder R, Riou JF, Teulade-Fichou MP, et al. Bisquinolinium compounds induce quadruplex-specific transcriptome changes in HeLa S3 cell lines. BMC Res Notes 2012;5:138
   PubMedGoogle Scholar
• Gomez D, Wenner T, Brassart B, et al. Telomestatin-induced telomere uncapping is modulated by POT1 through G-overhang extension in HT1080 human tumor cells. J Biol Chem 2006;281(50):38721-9
   PubMed Web of Science ®Google Scholar
• Di Antonio M, McLuckie KI, Balasubramanian S. Reprogramming the Mechanism of Action of Chlorambucil by Coupling to a G-Quadruplex Ligand. J Am Chem Soc 2014;136(16):5860-3
   PubMed Web of Science ®Google Scholar
• Piazz A, Boule JB, Lopes J, et al. Genetic instability triggered by G-quadruplex interacting Phen-DC compounds in Saccharomyces cerevisiae. Nucleic Acids Res 2010;38(13):4337-48
   PubMed Web of Science ®Google Scholar
• Smith JS, Chen Q, Yatsunyk LA, et al. Rudimentary G-quadruplex-based telomere capping in Saccharomyces cerevisiae. Nat Struct Mol Biol 2011;18(4):478-85
   PubMed Web of Science ®Google Scholar
• Piazza A, Serero A, Legoix-Ne JB, et al. Stimulation of gross chromosomal rearrangements by the human CEB1 and CEB25 minisatellites in Saccharomyces cerevisiae depends on G-quadruplexes or Cdc13. PLoS Genet 2012;8(11):e1003033
   PubMed Web of Science ®Google Scholar
• Lopes J, Piazza A, Bermejo R, et al. G-quadruplex-induced instability during leading-strand replication. EMBO J 2011;30(19):4033-46
   PubMed Web of Science ®Google Scholar